Print Icon
Dear Subscriber, 

2020 has been a year none of us will forget, bringing changes we could not have imagined. 

At the same time we’ve seen the power of what science can do when faced with such a global challenge. Proteomics has had a key part to play in tackling COVID-19, for example in the identification of potential drug targets and understanding the immune response to the disease.

Beyond the pandemic, we’ve seen a step change in our tools and technologies over the past 12 months, firmly establishing proteomics as a precision science with applications across the entire research pipeline. 

From advances in instrumentation and automation to combining machine learning with user-friendly analytical software, read our CTO Lukas Reiter’s LinkedIn article to find out how progress in proteomics is bringing a new era of discovery for the life sciences.

Whatever your vision for proteomics in 2021, we would love to help you make it a reality. Share your thoughts in the article's comment section or just get in touch to explore your ideas with our expert advisors. 

From all of us at Biognosys, we wish you a joyful holiday season and a peaceful and productive 2021. 

Best regards, 
The Biognosys Team

Can't read or view images? View in Browser

Want to edit your profile? Update Profile

Not interested? Unsubscribe

No more? Opt Out from Organization